Sign in
4

Changes in Ownership

Jade Biosciences, Inc. Filed Acc 0001415889-23-014773

CHIEF EXECUTIVE OFFICER sold 1,092 shares at $10.42 ($11,379)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

NOYES TIMOTHY P · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-11-01 Sale : show line 1 in the form 10b5-1 −1,092 $10.42 $11,379 0 D
Open-market sales · 1,092 sh · avg $10.42 · $11,379
Loading xslF345X05/form4-11032023_051101.xml…